Chemours Co

The Chemours Company reported a second-quarter net loss attributable to the company of $274 million, or $1.81 per diluted share, an improvement from a $380 million loss, or $2.53 per share, a year earlier. Net sales were roughly flat at $1.6 billion, as a 4% volume decline was offset by a 2% price increase and a 1% currency tailwind, while adjusted EBITDA fell 5% to $247 million and adjusted net income dropped 30% to $64 million. Free cash flow jumped 128% year over year with conversion reaching 46%, operating cash flow climbed to $158 million from $93 million, and net leverage fell to 4.4 times EBITDA as the company paid down 230 million euros of its B-3 euro-denominated term loan due August 2028. Advanced Performance Materials posted the weakest segment result, with net sales down 6% and adjusted EBITDA down 48% to $26 million, while Thermal & Specialized Solutions adjusted EBITDA margin rose to 36% from 35%. Chemours guided third-quarter net sales to fall 5% to flat sequentially, with Thermal & Specialized Solutions sales sliding mid-teens to 20% as refrigerant demand cools further.

A federal judge approved more than $2.5 billion in settlements reached by New Jersey with DuPont, 3M, Chemours, and Corteva to resolve claims over PFAS pollution. The settlement with DuPont entities, valued at more than $2 billion, is the largest environmental settlement ever achieved by a single state, while the combined settlements with DuPont entities and 3M total approximately $2.5 billion. Chemours and Corteva were part of DuPont prior to spinoffs. The judge called the total value an impressive windfall given litigation risks and said the settlements were fair, reasonable, and in the public interest.

New York State Attorney General Letitia James has sued chemical manufacturers including 3M and DuPont in state court over the sale of products containing toxic per- and polyfluoroalkyl substances, or PFAS. The lawsuit alleges that the defendant companies were aware of the toxicity of PFAS for years yet continued to use and sell them in consumer products, failed to adequately disclose the risks, and did not take effective measures to curb environmental contamination or mitigate harm. The defendants are 3M, DuPont, and DuPont spinoffs Chemours, Corteva, and EIDP. The state is seeking recovery of cleanup costs, proper warnings to consumers, damages and restitution, and civil penalties. PFAS are known as forever chemicals because they break down very slowly and have been linked to high cholesterol and kidney cancer. In May 2025, 3M agreed to a settlement of up to 450 million dollars over drinking water contamination in New Jersey, and Chemours reached a 450 million dollar settlement with the U.S. government in June of the same year.

Chemours has reached a settlement with the U.S. Environmental Protection Agency and West Virginia authorities to resolve PFAS-related claims at several facilities. The company will pay a $22.5 million civil penalty over three years and commit $90 million to mitigation projects over 15 years. The agreement clarifies future environmental compliance obligations and expands off-site drinking water programs, which is expected to increase environmental reserves. This settlement addresses one of the largest outstanding U.S. environmental disputes for Chemours, reducing near-term legal exposure but embedding higher long-term mitigation spending that could weigh on free cash flow.

The Trump administration has reached a multi-state settlement with Chemours over illegal PFAS discharges, marking the first time the federal government has settled with a manufacturer of these 'forever chemicals.' The agreement requires Chemours to pay an estimated $450 million in penalties and relief programs, including $22.5 million in civil penalties and $90 million over 15 years to reduce contamination in West Virginia, North Carolina, and New Jersey. The company will also spend $60 million on pollution-control systems at its West Virginia facility and $280 million to provide clean drinking water protection near its locations in West Virginia and New Jersey, while reducing PFAS releases in North Carolina pending an independent assessment. North Carolina's attorney general Jeff Jackson blasted the deal as a 'backroom deal' that does practically nothing to clean up the state's water, calling it 'an insult to the people of eastern North Carolina.' The settlement allows Chemours to continue manufacturing PFAS for commercial and military applications but aims to prevent further contamination.

Chemours has reached a settlement with the U.S. Environmental Protection Agency and the West Virginia Department of Environmental Protection to resolve claims related to PFAS discharges at its Washington Works, Fayetteville Works, and Chambers Works facilities. The company will pay a $22.5 million civil penalty over three years, with $15 million of that amount already accrued, and will fund $90 million in additional mitigation projects over the next 15 years to further reduce PFAS emissions and enhance off-site drinking water programs. The settlement also requires Chemours to expand its existing off-site drinking water programs in West Virginia, Ohio, and New Jersey, which is expected to increase its environmental reserves. The agreement, which remains subject to final court approval, provides greater clarity on future compliance requirements and supports the company's goal to reduce process emissions of fluorinated organic chemicals by 99% or more by 2030. Separately, Chemours resolved litigation with the West Virginia Rivers Coalition for less than $1 million over alleged Clean Water Act violations at its Washington Works site.